These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11880643)

  • 1. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.
    Pletnev AG; Putnak R; Speicher J; Wagar EJ; Vaughn DW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3036-41. PubMed ID: 11880643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
    Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
    Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
    Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
    Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
    Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
    Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response.
    Anwar A; Chandrasekaran A; Ng ML; Marques E; August JT
    Virology; 2005 Feb; 332(1):66-77. PubMed ID: 15661141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.
    Yamshchikov G; Borisevich V; Seregin A; Chaporgina E; Mishina M; Mishin V; Kwok CW; Yamshchikov V
    Virology; 2004 Dec; 330(1):304-12. PubMed ID: 15527855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
    Blaney JE; Johnson DH; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
    J Virol; 2001 Oct; 75(20):9731-40. PubMed ID: 11559806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of chimeric West Nile viruses.
    Borisevich V; Seregin A; Nistler R; Mutabazi D; Yamshchikov V
    Virology; 2006 Jun; 349(2):371-81. PubMed ID: 16545851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
    Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.